ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,733.50
5.00 (0.29%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 0.29% 1,733.50 1,732.50 1,733.00 1,739.50 1,724.50 1,733.00 4,237,056 16:35:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.48 71.35B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,728.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,739.50p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £71.35 billion. Gsk has a price to earnings ratio (PE ratio) of 14.48.

Gsk Share Discussion Threads

Showing 18876 to 18899 of 33150 messages
Chat Pages: Latest  762  761  760  759  758  757  756  755  754  753  752  751  Older
DateSubjectAuthorDiscuss
16/1/2019
15:14
Upgrading French facility for this aim
zicopele
16/1/2019
15:10
Significantly more than 1bn if they intend to produce vaccines in high teens of millions for USA market.
zicopele
16/1/2019
13:57
Alphorn:
The situation wrt IP on vaccines is often complex, and I suggest that for Shingrix there may exist multiple elements of patent cover.

Just as there are many forms of vaccines and components to vaccines-particular compositions, delivery systems, components, and distribution networks-there are a variety of intellectual property (IP) protections applicable for vaccines. IP rights such as patent, copyright, trademarks, plant breeders' rights, and trade secrets may all be applicable to vaccines. Thus, discussion of IP rights and vaccines should not begin and end with the application of one IP right to a vaccine. The discussion should engage considerations of multiple IP rights applicable to a vaccine and how these can be utilized in an integrated manner in a strategy aimed at supporting the development and distribution of the vaccine. Such an approach to IP rights to vaccines allows for the integrated rights to be considered in light of the justifications for protecting vaccines with IP rights, as well as the issues relating to specific IP rights for vaccines, such as compulsory license regimes, available humanitarian purpose IP credits, etc. To view vaccines as the subject of multiple IP protections involves a refocusing, but the outcome can provide significant benefits for vaccine development and distribution.

tradermichael
16/1/2019
13:34
It's estimated at around $1 billion in revenue a year, Adavair it ain't!,
Helpful though.

essentialinvestor
16/1/2019
13:32
Alphorn: SHINGRIX is administered as a 2-dose series:
The second dose should be administered anytime between 2 and 6 months after the first dose to complete the 2-dose series as directed.1

tradermichael
16/1/2019
12:51
Shingrix must be one of the main reasons for EW having confidence in a future GSK without consumer products.

It would appear to bode well for future but share is suffering short term.

zicopele
16/1/2019
12:07
That was an issue with Imigran; in some countries it was also given for headaches which, of course, did not work. An interesting snippet on that subject was that there were more migraines reported north of the Thames than the south at the time.

Btw does anyone have the IP details for Shingrix. When does it come off patent?
Also there may be a need for re-vaccination at a later date which would also help sales. Last time that I looked that was not clear.

alphorn
16/1/2019
12:02
Because a second shot is necessary to give optimum protection, it is important that supply is maintained in existing markets to existing patients. Otherwise there is a risk of confidence in the product.

Advertising and new licence application activity etc. should be held back to interface with upscaled manufacturing capability.

tradermichael
16/1/2019
11:47
Shingrix supply problems are hampering share price Such a pity as this an absolute blockbuster.

Will underpin gsk for years

zicopele
16/1/2019
10:29
Roger, there were unsound points made by both sides, probably more by the remain side and certainly more money spent by the remainers.

I’m pretty sure no government would trust us with another referendum in the future. What is also interesting is that many labour constituencies are split.

We do not get much press about the high level of EU youth unemployment and their economic woes which of course are continually ignored by Brussels. We must also realise that the unelected Brussels elite were always going to make it difficult for us to leave especially as we are net contributors. In the absence of a clean and managed break, Boris’ solution this morning appears to be the way forward.

chessman2
16/1/2019
09:41
@WBthere is nothing in the concept of democracy that prevents decisions from being reviewed and an alternative course of action set. Those that spout off that another referendum is going against democracy especially when it is clear that the result of that vote was based largely on a load of half truths and political spin are in themselves being undemocratic in the furtherance of their own personal agenda
rogerrail
16/1/2019
09:19
Stronger £ this morning.

Morning all.

philanderer
16/1/2019
07:37
Exactly right wbecki
tradermichael
16/1/2019
00:07
What WB said 👍
philanderer
15/1/2019
22:27
maybe it should be like proportional representation. only a 52% brexit.
ccraig69
15/1/2019
21:42
LEAVE and WTO

Mockbeggar
Posted January 15, 2019 at 9:51 am | Permalink
These figures were published by our host in this diary some time ago>

Official HMT and OBR figures for 2016:

Total gross contribution to EU £23.148 bn (£445m/week)
Gross contribution less rebate £17.865 bn (£343m/wek)
Gross contribution less money paid back
through EU programmes £11.73bn (£225m/week)

Gross contributions are comprised of:

Customs revenue £3.347 bn
VAT EU share £3.647 bn
GNI levy £16.154 bn

I don’t have the latest figures I’m afraid.

xxxxxy
15/1/2019
20:58
Whether the country is split or not
52% voted LEAVE
48% voted REMAIN

Only CETA(including NI) or WTO No Deal brexit honours the reffy result - everything else is Remain in some form

So what has to be done, has to be done for Democracy to survive.

If remoaners want to overturn the vote, democracy falls. As simple as that

wbecki
15/1/2019
20:25
No chance of a General Election. Corbyn was hopeless today.

May will breeze a confidence vote tomorrow. DUP onside.

FTSE futures off 10 points at the moment

philanderer
15/1/2019
19:53
Most people I know are fed up to the back teeth of politics and politicians another election is the last thing they want.

Corbyn was poor today in what should have been his time to shine.

Market barley moved.

tim 3
15/1/2019
19:38
General election is my bet.
montyhedge
15/1/2019
18:47
Listening to May at the moment and doesn't look like she wants an extension. All I can think of is that she's hoping the EU will give a fixed date on the backstop and MP's vote again.

Agree re 'defensives' with GSK having a good afternoon as the £ fell away

philanderer
15/1/2019
18:32
But good for defensive stocks, ie GSK.
montyhedge
15/1/2019
18:32
Tomorrow Corbyn going to ask for a no confidence vote in gov, when she loses tonight.Election odds on to me. Corbin is favourite with the bookies to be next PM, I shall leave UK, lol that's how I see it.
montyhedge
15/1/2019
18:12
Hi monty , don't think we'll see a General Election , more likely an extension to Article 50 dragging this brexit b*ll*x into the summer.
philanderer
Chat Pages: Latest  762  761  760  759  758  757  756  755  754  753  752  751  Older

Your Recent History

Delayed Upgrade Clock